SLC25A20 and maple syrup urine disease: Such a diagnostic approach allowed survival and treatment of 4 neonates (maple syrup urine disease [MSUD], propionic acidemia [PA], carnitine-acylcarnitine translocase deficiency and HT1) (Table 9).